South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...
21h
News Medical on MSNMangoes may help reduce insulin resistance in adults who are overweight or obeseNew research has uncovered a potential way to improve cardiometabolic health: fresh mangoes. A study recently published in ...
Biocon Biologics partners with Civica to enhance access to Insulin Aspart in the US, no tech transfer involved.
Biocon Biologics' own Insulin Aspart drug product for the US is currently under review by the US Food and Drug Administration ...
Researchers from the German Diabetes Center (DDZ) and the Heinrich Heine University Düsseldorf (HHU) have studied the ...
Civica will commercialize the medicine for patients in the United States, after completion of development work and clinical ...
2don MSN
California dedicated $100 to manufacturing insulin for diabetic residents. That effort is taking longer than Gov. Gavin ...
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), and Civica, Inc. (Civica), a not-for-profit generic drug and ...
New research finds mangos may be key to reducing insulin resistance, improving insulin sensitivity in adults who are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results